Today, Fiser is committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nation's prices. It's going to have a huge impact on bringing Medicaid costs down. This is a critical step forward to our work and to improve healthcare and hardworking lowincome Americans, especially low-income Americans, will be helped so greatly.In addition, Fiser is agreeing to provide some of their most popular current medications to all consumers at heavily discounted prices of any ...

Pharmaceutical Industry Dynamics - The White House and President Trump have been pushing for lower prescription drug costs for months, culminating in an announcement with Pfizer [2] - The administration's overall goal is to lower US prescription drug costs, which are historically higher than in other nations [3] - President Trump announced a deal between Medicaid and Pfizer to lower drug prices, along with a new website called Trump RX for Americans to buy medications [1] Pfizer Deal Specifics - Pfizer has pledged to lower some prescription drug costs, but the specific drugs involved are not yet known [2][3] - The CEO of Pfizer is in attendance and will offer remarks, with other drug makers potentially following suit [3][5] Trump RX Website - Trump RX is intended to be a direct-to-consumer website named after the president [4] - Details on how the Trump RX website will work and which drugs will be included are still pending [4][5] - The aim is to cut out intermediaries and allow people to order prescription drugs directly through Pfizer [5]

Company Updates - Spotify shares dropped following the announcement that co-founder and CEO Daniel Ek will step down, with co-presidents Gustav Soderstrom and Alex Norstrom set to take over as co-CEOs [2][4] - Instacart operator Maplebear saw its shares tumble after BTIG downgraded its rating from "buy" to "neutral," citing increased competition in the food delivery sector [2] - Firefly Aerospace experienced a significant decline in shares after one of its rocket boosters exploded during preflight tests [2] Market Reactions - Pfizer shares gained after the pharmaceutical company reached a deal with the Trump administration to lower drug prices [3][4] - CoreWeave shares surged following the announcement of a new agreement with Meta Platforms valued at up to $14.2 billion [3] - Lamb Weston Holdings shares increased after the company reported better-than-expected sales driven by improved restaurant demand [3] Economic Indicators - Major U.S. equities indexes, including the Dow, S&P 500, and Nasdaq, edged lower amid concerns over a potential government shutdown [4]

Today, Pfizer's committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nations. Prices is going to have a huge impact on bringing Medicaid costs down like nothing else. I told you that in my first term, I was so proud of the fact that for the first time in 28 years, drug prices came down and I had a news conference that explained it was 1/10 of 1%, but it was down.And here we're talking about, in one case, over 1,000%. This is a critical step forward to wor ...

Core Points - Pfizer is committing to offer all prescription medications to Medicaid at the most favored nations pricing, which is expected to significantly reduce Medicaid costs [1] - The company will provide popular medications at discounts ranging from 50% to 100% for all consumers [2] - New medications introduced by Pfizer will also be sold at reduced most favored nation costs, aligning U.S. prices with those of other countries [4] - Pfizer plans to invest $70 billion to reshore domestic manufacturing facilities and fund research and development in the United States [4][5]

辉瑞与美国政府达成药品定价协议后，美国制药商股价上涨。 来源：滚动播报 ...

Core Insights - Pfizer Inc. is planning to announce measures to lower prescription drug prices, particularly for Medicaid patients, in collaboration with President Trump [1][2] - The initiative includes a "most favored nation" pricing model for select medicines and discounted direct-to-consumer sales through a government website called TrumpRx [2][3] - Pfizer will invest $70 billion in research, development, and domestic manufacturing, indicating a significant expansion of its US operations [4] Pricing Strategy - The "most favored nation" pricing policy will require Pfizer to reduce Medicaid prices and align US drug prices with those in other countries for future drugs [5] - Direct-to-consumer discounts will be available through the TrumpRx platform, allowing Americans to purchase certain high-volume drugs at government-negotiated rates [3][5] Government Support and Pressure - The White House has expressed strong support for the initiative, highlighting President Trump's efforts to lower healthcare costs compared to other political actions [5] - Trump's administration has previously sent letters to major drugmakers, including Pfizer, demanding compliance with pricing reductions by September 29 [6] Domestic Production and Tariffs - In addition to price reductions, the Trump administration is pushing for increased domestic production from drug manufacturers [7] - Plans have been announced to impose 100% tariffs on imported branded or patented drugs unless manufacturers establish production facilities in the US, with tariffs set to begin on October 1 [7]

President Donald Trump speaks from the Oval Office to announce that Pfizer has agreed to take measures to lower U.S. drug prices, including selling its existing drugs to Medicaid patients at the lowest price offered in other developed nations. ...

Core Points - Americans have historically paid significantly higher prices for prescription drugs compared to other countries, with prices being 10 to 15 times higher for the same products [1][2] - Pharmaceutical companies derive 75% of their profits from the U.S. market, despite the U.S. only representing 4% of the global population and 13% of prescription drug consumption [2][3] - An executive order has been signed to combat high drug prices, with Pfizer committing to offer medications to Medicaid at the most favored nation's prices, which is expected to significantly reduce costs [4][5] Pricing and Cost Reductions - Pfizer will provide some medications at discounts ranging from 50% to 100% for consumers, with direct online purchasing available through a federal government-operated website [5][6] - New medications introduced by Pfizer will be sold at reduced prices comparable to those in other countries [6][7] - The initiative aims to end the era of global price gouging, with potential reductions in drug prices reaching up to 1,000% in some cases [5][12] Investment and Manufacturing - Pfizer plans to invest $70 billion to reshore domestic manufacturing facilities, bringing production back to the U.S. [7][8] - This investment will also fund research and development within the United States, aiming to enhance the domestic pharmaceutical industry [8] Trade Practices and Negotiations - The administration is investigating unfair trade practices that have led to American consumers subsidizing global healthcare costs [10] - Other countries are being pressured to align with U.S. pricing strategies, with potential tariffs imposed on those that do not comply [13][14]

Core Points - Pfizer Inc. has reached a historic agreement with the Trump Administration to lower prescription medicine prices for U.S. patients while enhancing the country's leadership in biopharmaceutical innovation [1] - The agreement addresses four key points outlined in the President's letter dated July 31, indicating Pfizer's commitment to ensuring Americans receive drug prices comparable to those available in other countries [1]